blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2360183

EP2360183 - ANTIBODY PURIFICATION METHOD BY MIXED MODE CHROMATOGRAPHY UTILIZING AN ARGININE-CONTAINING LOADING SOLUTION [Right-click to bookmark this link]
Former [2011/34]ANTIBODY PURIFICATION METHOD
[2016/09]
StatusNo opposition filed within time limit
Status updated on  02.06.2017
Database last updated on 27.07.2024
Most recent event   Tooltip21.09.2018Lapse of the patent in a contracting state
New state(s): MT		published on 24.10.2018  [2018/43]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1 Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045 / JP
[2011/34]
Inventor(s)01 / SUENAGA, Masato
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
4720 Mitsui-Aza-Takeda
Hikari-shi Yamaguchi 743-8502 / JP
02 / HAYAKAWA, Takeshi
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
4720 Mitsui-Aza-Takeda
Hikari-shi Yamaguchi 743-8502 / JP
03 / MURAMOTO, Takuya
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
4720 Mitsui-Aza-Takeda
Hikari-shi Yamaguchi 743-8502 / JP
 [2016/30]
Former [2011/34]01 / SUENAGA, Masato
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 4720 Mitsui-Aza-Takeda
Hikari-shi Yamaguchi 743-8502 / JP
02 / HAYAKAWA, Takeshi
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 4720 Mitsui-Aza-Takeda
Hikari-shi Yamaguchi 743-8502 / JP
03 / MURAMOTO, Takuya
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 4720 Mitsui-Aza-Takeda
Hikari-shi Yamaguchi 743-8502 / JP
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[2016/30]
Former [2011/34]von Kreisler Selting Werner
Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln / DE
Application number, filing date09833510.218.12.2009
[2011/34]
WO2009JP71182
Priority number, dateJP2008032420219.12.2008         Original published format: JP 2008324202
[2011/34]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010071208
Date:24.06.2010
Language:JA
[2010/25]
Type: A1 Application with search report 
No.:EP2360183
Date:24.08.2011
Language:EN
[2011/34]
Type: B1 Patent specification 
No.:EP2360183
Date:27.07.2016
Language:EN
[2016/30]
Search report(s)International search report - published on:JP24.06.2010
(Supplementary) European search report - dispatched on:EP01.02.2013
ClassificationIPC:C07K16/22, C07K1/18, C07K1/20, C07K1/22, C07K1/36, C07K16/00
[2013/10]
CPC:
C07K1/36 (EP,US); C07K16/00 (EP,US); C07K16/22 (EP,US)
Former IPC [2011/34]C07K16/22, C07K1/18, C07K1/20, C07K1/22
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/30]
Former [2011/34]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:ANTIKÖRPERREINIGUNGSVERFAHREN MITTELS "MIXED-MODE" CHROMATOGRAPHY UNTER VERWENDUNG EINER ARGININE-HALTIGEN BELADUNGSLÖSUNG[2016/09]
English:ANTIBODY PURIFICATION METHOD BY MIXED MODE CHROMATOGRAPHY UTILIZING AN ARGININE-CONTAINING LOADING SOLUTION[2016/09]
French:Méthode de purification anticorps par chromatographie a mode mixte utilisant une solution de chargement contenant arginine[2016/09]
Former [2011/34]ANTIKÖRPERREINIGUNGSVERFAHREN
Former [2011/34]ANTIBODY PURIFICATION METHOD
Former [2011/34]MÉTHODE DE PURIFICATION D'ANTICORPS
Entry into regional phase17.06.2011Translation filed 
17.06.2011National basic fee paid 
17.06.2011Search fee paid 
17.06.2011Designation fee(s) paid 
17.06.2011Examination fee paid 
Examination procedure17.06.2011Examination requested  [2011/34]
02.09.2013Amendment by applicant (claims and/or description)
13.03.2015Despatch of a communication from the examining division (Time limit: M06)
15.09.2015Reply to a communication from the examining division
16.02.2016Communication of intention to grant the patent
20.06.2016Fee for grant paid
20.06.2016Fee for publishing/printing paid
20.06.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.03.2015
Opposition(s)02.05.2017No opposition filed within time limit [2017/27]
Fees paidRenewal fee
28.12.2011Renewal fee patent year 03
19.12.2012Renewal fee patent year 04
27.12.2013Renewal fee patent year 05
19.12.2014Renewal fee patent year 06
18.12.2015Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.12.2009
AT27.07.2016
BE27.07.2016
CY27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
MK27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
TR27.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
IE18.12.2016
LU18.12.2016
MT18.12.2016
[2018/43]
Former [2018/29]HU18.12.2009
AT27.07.2016
BE27.07.2016
CY27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
MK27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
TR27.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
IE18.12.2016
LU18.12.2016
Former [2018/28]HU18.12.2009
AT27.07.2016
BE27.07.2016
CY27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
MK27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
IE18.12.2016
LU18.12.2016
Former [2017/49]AT27.07.2016
BE27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
IE18.12.2016
LU18.12.2016
Former [2017/45]AT27.07.2016
BE27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/37]AT27.07.2016
BE27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/31]AT27.07.2016
BE27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/13]AT27.07.2016
BE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
NL27.07.2016
PL27.07.2016
SE27.07.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/11]AT27.07.2016
BE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
NL27.07.2016
PL27.07.2016
SE27.07.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/10]BE27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
NL27.07.2016
PL27.07.2016
SE27.07.2016
NO27.10.2016
IS27.11.2016
Former [2017/09]FI27.07.2016
IT27.07.2016
LT27.07.2016
NL27.07.2016
NO27.10.2016
Former [2017/07]LT27.07.2016
Documents cited:Search[A]WO2005082926  (AMERSHAM BIOSCIENCES AB [SE], et al) [A] 1-9 * the whole document *;
 [A]US2008177048  (GAGNON PETER S [US]) [A] 1-9 * the whole document *;
 [E]US8017740  (GAGNON PETER S [US]) [E] 1-9* the whole document *;
 [XI]  - ARAKAWA T ET AL, "MEP chromatography of antibody and Fc-fusion protein using aqueous arginine solution", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, vol. 63, no. 2, doi:10.1016/J.PEP.2008.09.011, ISSN 1046-5928, (20080926), pages 158 - 163, (20080926), XP025686812 [X] 1,5-8 * the whole document * [I] 2-4,9

DOI:   http://dx.doi.org/10.1016/j.pep.2008.09.011
 [A]  - "Capto adhere, Instructions 28-9064-05 AA Multimodal media", Capto adhere, Instructions 28-9064-05 AA Multimodal media, GE Healthcare, (20061001), XP055050471 [A] 1-9 * the whole document *
 [A]  - SOMMERFELD S ET AL, "Challenges in biotechnology production-generic processes and process optimization for monoclonal antibodies", CHEMICAL ENGINEERING AND PROCESSING, ELSEVIER SEQUOIA, LAUSANNE, CH, (20051001), vol. 44, no. 10, doi:10.1016/J.CEP.2005.03.006, ISSN 0255-2701, pages 1123 - 1137, XP004922715 [A] 1-9 * tables 1-3 *

DOI:   http://dx.doi.org/10.1016/j.cep.2005.03.006
 [A]  - ARAKAWA T ET AL, "Biotechnology applications of amino acids in protein purification and formulations", AMINO ACIDS ; THE FORUM FOR AMINO ACID AND PROTEIN RESEARCH, SPRINGER-VERLAG, VI, (20070316), vol. 33, no. 4, doi:10.1007/S00726-007-0506-3, ISSN 1438-2199, pages 587 - 605, XP019565540 [A] 1-9 * the whole document *

DOI:   http://dx.doi.org/10.1007/s00726-007-0506-3
 [A]  - ARAKAWA ET AL, "The effects of arginine on protein binding and elution in hydrophobic interaction and ion-exchange chromatography", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, (20070426), vol. 54, no. 1, doi:10.1016/J.PEP.2007.02.010, ISSN 1046-5928, pages 110 - 116, XP022056642 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1016/j.pep.2007.02.010
 [A]  - ARAKAWA T ET AL, "Elution of antibodies from a Protein-A column by aqueous arginine solutions", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, (20040801), vol. 36, no. 2, doi:10.1016/J.PEP.2004.04.009, ISSN 1046-5928, pages 244 - 248, XP004520288 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1016/j.pep.2004.04.009
 [A]  - TSUMOTO ET AL, "Arginine improves protein elution in hydrophobic interaction chromatography", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, (20070601), vol. 1154, no. 1-2, doi:10.1016/J.CHROMA.2007.02.061, ISSN 0021-9673, pages 81 - 86, XP022101506 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1016/j.chroma.2007.02.061
 [A]  - TUGCU NIHAL ET AL, "Maximizing productivity of chromatography steps for purification of monoclonal antibodies", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, vol. 99, no. 3, doi:10.1002/BIT.21604, ISSN 0006-3592, (20080215), pages 599 - 613, (20070806), XP002556043 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1002/bit.21604
 [A]  - CHEN ET AL, "Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, (20071226), vol. 1177, no. 2, doi:10.1016/J.CHROMA.2007.07.083, ISSN 0021-9673, pages 272 - 281, XP022401695 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1016/j.chroma.2007.07.083
 [A]  - EJIMA ET AL, "Effective elution of antibodies by arginine and arginine derivatives in affinity column chromatography", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS INC, NEW YORK, (20051015), vol. 345, no. 2, doi:10.1016/J.AB.2005.07.004, ISSN 0003-2697, pages 250 - 257, XP005086464 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1016/j.ab.2005.07.004
 [A]  - EJIMA ET AL, "Arginine as an effective additive in gel permeation chromatography", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, (20051111), vol. 1094, no. 1-2, doi:10.1016/J.CHROMA.2005.07.086, ISSN 0021-9673, pages 49 - 55, XP005131684 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1016/j.chroma.2005.07.086
 [A]  - NAKAKIDO M ET AL, "Structure-based analysis reveals hydration changes induced by arginine hydrochloride", BIOPHYSICAL CHEMISTRY, NORTH-HOLLAND, AMSTERDAM, NL, vol. 137, no. 2-3, doi:10.1016/J.BPC.2008.07.009, ISSN 0301-4622, (20081001), pages 105 - 109, (20080809), XP025431718 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1016/j.bpc.2008.07.009
 [A]  - TSUMOTO KOHEI ET AL, "Review: Why is Argine Effective in SUppressing Aggregation?", PROTEIN AND PEPTIDE LETTERS, BENTHAM SCIENCE PUBLISHERS, NL, (20051001), vol. 12, no. 7, doi:10.2174/0929866054696109, ISSN 0929-8665, pages 613 - 619, XP009090675 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.2174/0929866054696109
 [A]  - Hans J Johansson, "A novel multimodal anion exchanger designed for monoclonal antibody purification", IBC's 18th International, Antibody Development &Production February-March, 2007, (20070301), URL: http://www.gelifesciences.co.jp/newsletter/downstream/pdf/novel_anion_exchanger.pdf, (20130122), XP055050493 [A] 1-9 * the whole document *
International search[Y]JP2006242957  (AJINOMOTO KK);
 [Y]JP2008505851  (GE HEALTHCARE BIOSCIENCES AB.);
 [Y]JP2008517906  (GE HEALTHCARE BIOSCIENCES AB.);
 [Y]  - TSUTOMU ARAKAWA ET AL., "The effects of arginine on protein binding and elution in hydrophobic interaction and ion-exchange chromatography", PROTEIN EXPRESSION AND PURIFICATION, (2007), vol. 54, pages 110 - 116, XP022056642

DOI:   http://dx.doi.org/10.1016/j.pep.2007.02.010
by applicantUS5530101
 US5585089
 JP2006242957
 US2007065385
 WO2007115049
    - J. IMMUNOL., (1992), vol. 148, page 1149
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.